BPC-157: can it really help you heal faster?

BPC-157 is a lab-made peptide people use hoping to heal injuries faster. Encouraging results come mostly from animal studies, so whether it helps people is still open. Since October 2026, regulators have said they won't act against licensed pharmacies that compound it under set conditions. If your goal is to recover, move better or feel stronger, a physician can point you to options with stronger evidence.

Reviewed by Darshan Patel, MD, Obesity medicine physician, on 2026-11-12. Next review 2026-12-12.

Book my consultation Video consultations with an Aayu Well physician. Most major insurance accepted, plus convenient cash pay options.

Why people are curious about BPC-157

It's easy to see the appeal. BPC-157 has a reputation online as a "healing peptide," and people look it up when a tendon, a joint or their gut just won't settle down. Most have already tried rest, stretching and patience, and want something that works faster.

That's a good goal. The real question is whether BPC-157 is the best way to get there.

What the research shows so far

Evidence grade D: early. Most of what we know comes from animal and lab studies. How we grade evidence.

• In animals: dozens of studies, many from one research group in Croatia, report faster healing of tendon, muscle and gut tissue in rats and mice. That's promising, though results in animals often don't carry over to people.
• In people: a handful of small reports with no comparison group, such as patients who had it injected into the knee for pain. Without a comparison group, it's hard to tell whether BPC-157 or time did the healing.
• Still open: whether it works in a proper trial, the right amount, and what it does over months or years.

Your goal, with stronger evidence behind it

Most people who ask about BPC-157 want one of three things. Here's what has been tested in people.

• Move without pain. For people carrying extra weight, losing some of it takes load off the knees with every step, and in a large trial of people with knee arthritis, diet and exercise together eased pain. For a specific injury, a sports medicine physician or physical therapist is a great first stop.
• Keep your muscle while you lose fat. Protein at every meal and strength work twice a week protect muscle as the weight comes off. At Aayu Well, a registered dietitian helps you turn that into meals you can actually make.
• Feel better in your body. For people living with obesity, GLP-1 medicines such as semaglutide and tirzepatide have been tested in large trials with thousands of people. Under specialist care, they quiet hunger and improve health numbers.

Aayu Elevate™ puts this together: video visits with an obesity medicine physician, a registered dietitian, and medicine when it's right for you. Most major insurance accepted, plus convenient cash pay options. Book my consultation

Is BPC-157 legal now?

Yes, with conditions. In October 2026, HHS said it won't take action against licensed pharmacies and physicians that compound BPC-157 for a specific patient, as long as they follow ten conditions. FDA had listed it as a safety concern from 2023 until April 2026. This isn't FDA approval, and some states set their own rules. See which peptides can be compounded.

Good to know before you try it

• It isn't FDA-approved, and no one has followed people taking it for months or years.
• Skip it if you're pregnant or breastfeeding, if you've had cancer (in animal studies it encourages new blood vessel growth), or if you're an athlete who gets drug tested.
• If you use any peptide, get it with a prescription from a licensed pharmacy. Products labeled research use only aren't made or tested for people. Here's why that label matters.
• Tell every physician who treats you what you take, especially if you're on a GLP-1.

Where Aayu Well stands

We don't prescribe BPC-157 right now. We're following the research and the new pharmacy rules closely, and we review this page every month.

What we can help with today is usually what sits behind the question: weight, joints, energy, sleep and mood. Bring your peptide questions to your first visit. Your physician will give you a straight answer and a plan built around you.

Questions people ask

Can I talk to an Aayu Well physician about peptides?

Yes, and we'd encourage it. Bring your questions to your visit. We don't prescribe BPC-157 right now, but your physician will go over the evidence with you, review everything you take, and build a plan for the goal behind the question, whether that's weight, recovery, energy or sleep.

Is BPC-157 legal?

As of November 12, 2026, federal regulators say they won't take action when a licensed pharmacy or physician compounds BPC-157 for a specific patient under ten conditions. It still isn't an FDA-approved drug, and some states set their own rules.

Is BPC-157 safe?

It hasn't been studied in people long enough to say. Most of the research is in animals, so side effects and long-term effects in people haven't been measured yet.

Can I take it with a GLP-1 like Wegovy or Zepbound?

No studies have looked at the two together, so it's worth a conversation first. Tell the physician who prescribes your GLP-1 about any peptide you use.

Is BPC-157 banned in sports?

Yes. The World Anti-Doping Agency lists it as prohibited at all times, so athletes who are drug tested should skip it.

Sources

1. HHS: Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances, Appendices A and B (October 2026)
2. Federal Register notice FR Doc. 2026-22192, 91 FR 68526 (October 30, 2026)
3. Seiwerth S, Milavic M, Vukojevic J, et al. Stable gastric pentadecapeptide BPC 157 and wound healing. Front Pharmacol. 2021;12:627533. doi:10.3389/fphar.2021.627533
4. Lee E, Padgett B. Intra-articular injection of BPC 157 for multiple types of knee pain. Altern Ther Health Med. 2021;27(4):8-13.
5. Messier SP, Mihalko SL, Legault C, et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA. 2013;310(12):1263-1273. doi:10.1001/jama.2013.277669
6. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183
7. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038
8. World Anti-Doping Agency: 2026 Prohibited List, in force from January 1, 2026 (BPC-157 under S0, non-approved substances)